SANOFI-EFC3313

Study Sponsor : Sanofi

Study Title

Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer

Medicine or Vaccine (generic name)

Oxaliplatin

Sponsor Identification Number

EFC3313

Trial Registry Identification Number(#'s)

NCT00275210

Medical Condition

Colonic Neoplasms

Phase

Phase 3

Link to study details on the Sanofi Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Not available

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Datasets and document are available as per Sanofi Policy and criteria

Date Added to this Site

August 2016